After only five years on the consumer market, the IDEAL IMPLANT® Structured Breast Implant is proving to be a disruptive technology, with strong clinical data that better addresses women’s concerns.
DALLAS (PRWEB) March 03, 2020
Ideal Implant Incorporated Founder and CEO, Robert S Hamas, MD, was invited to present the latest breast implant technology at the IMCAS Innovation Shark Tank 2020 in Paris, France in January. The international conference featured start-ups and new innovations in the dermatology, plastic surgery, and aesthetic science industries that promise to revolutionize medical practices in their fields.
“After only five years on the consumer market, the IDEAL IMPLANT® Structured Breast Implant is proving to be a disruptive technology, with strong clinical data that better addresses women’s concerns,” Dr. Hamas explained to attendees. “It’s patented, unique internal structure offers women the natural feel and look of silicone gel implants, yet a woman can look in the mirror and know her implants are intact, while having the peace of mind of only saline inside. The design has captured the benefits of other types of implants without their drawbacks.”
Recent market studies show that peace of mind is increasingly a factor when women choose a breast implant. As the IDEAL IMPLANT eight-year clinical trial data demonstrated significantly lower rates of complications such as rupture and capsular contracture over silicone gel implants, while allowing for instant rupture detection without the MRIs required with silicone gel implants, women are pressuring surgeons to offer the new technology. As a result, the company is investing in expanded production facilities to meet the overwhelming demand the IDEAL IMPLANT design has seen since becoming available in 2015.
“We received many outstanding applications and had the very difficult mission of selecting the 15 start-ups that would pitch their innovations live to the jury and audience of high profile venture-capitals, industry leaders and KOL physicians,” explained an IMCAS spokesperson. “Among the submissions, Ideal Implant was clearly a very interesting innovation with the potential to disrupt its industry, and we were glad to have them take part in this Innovation Shark Tank.”
About Ideal Implant
Ideal Implant Incorporated, founded in 2006, is privately held and based in Dallas, TX. The company has developed the IDEAL IMPLANT, designed the manufacturing processes including proprietary robotic shell fabrication technology, conducted a large US clinical trial, and received PMA approval from FDA and Health Canada in 2014. The marketing strategy has been focused on female consumers, who make the ultimate decision on their choice of implant. Growth in consumer demand has been rapid since commercial launch in 2015 - the IDEAL IMPLANT brand has become well recognized in the plastic surgery market, and plans are underway for expansion of manufacturing capacity to meet the growing demand. For more information, visit https://idealimplant.com/